Impact of the Society of Surgical Oncology-American Society for Radiation Oncology Margin Guidelines on Breast-Conserving Surgery and Mastectomy Trends.

[1]  Robert C. G. Martin,et al.  Evaluating the Effect of Margin Consensus Guideline Publication on Operative Patterns and Financial Impact of Breast Cancer Operation. , 2018, Journal of the American College of Surgeons.

[2]  Rhona J. Souers,et al.  Breast Specimen Processing and Reporting With an Emphasis on Margin Evaluation: A College of American Pathologists Survey of 866 Laboratories. , 2018, Archives of pathology & laboratory medicine.

[3]  C. Murphy,et al.  Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines. , 2017, American journal of surgery.

[4]  Reshma Jagsi,et al.  Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management , 2017, JAMA oncology.

[5]  Caitlin R Patten,et al.  Changes in margin re‐excision rates: Experience incorporating the “no ink on tumor” guideline into practice , 2017, Journal of surgical oncology.

[6]  A. Jager,et al.  Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival , 2017, Breast Cancer Research and Treatment.

[7]  C. Baliski,et al.  Influence of the SSO/ASTRO Margin Reexcision Guidelines on Costs Associated with Breast-Conserving Surgery , 2017, Annals of Surgical Oncology.

[8]  C. V. Deurzen.  Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study , 2016 .

[9]  A. Chagpar,et al.  Factors Associated with Persistently Positive Margin Status after Breast-Conserving Surgery in Women with Breast Cancer: An Analysis of the National Cancer Database , 2016, The American surgeon.

[10]  M. Morrow,et al.  Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center , 2016, Annals of Surgical Oncology.

[11]  C. Hudis,et al.  Invasive breast cancer version 1.2016 , 2016 .

[12]  A. Giuliano,et al.  Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer , 2015, Annals of Surgical Oncology.

[13]  T. Sarantou,et al.  Margin re‐excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model , 2015, Journal of surgical oncology.

[14]  K. Hunt,et al.  Assessment of Practice Patterns Following Publication of the SSO–ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer , 2015, Annals of Surgical Oncology.

[15]  R. Weigel,et al.  Surgical Management of Breast Cancer in 2010–2011 SEER Registries by Hormone and HER2 Receptor Status , 2015, Annals of Surgical Oncology.

[16]  S. Schnitt,et al.  The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. , 2015, Archives of pathology & laboratory medicine.

[17]  E. Winer,et al.  Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast , 2015, Annals of Surgical Oncology.

[18]  Brittany Lapin,et al.  Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010. , 2014, JAMA surgery.

[19]  J. Griggs,et al.  Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Peppercorn,et al.  Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer , 2014, Annals of surgical oncology.

[21]  Seema A Khan,et al.  Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Morrow,et al.  The challenge of developing quality measures for breast cancer surgery. , 2012, JAMA.

[23]  M. Morrow,et al.  Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Les Irwig,et al.  Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. , 2010, European journal of cancer.

[25]  C. Ko,et al.  Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Niemierko,et al.  Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy , 2016, Breast Cancer Research and Treatment.

[27]  C. Greenberg,et al.  Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM Database Following the SSO-ASTRO “No Ink on Tumor” Guidelines , 2016, Annals of Surgical Oncology.

[28]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.